Tivozanib: is total VEGFR inhibition the way to success in terms of tolerability and efficacy in advanced kidney cancer?

por Gross-Goupil, Marine, Ravaud, Alain
Publicado 2012

Axitinib: A Review of its Safety and Efficacy in the Treatment of Adults with Advanced Renal Cell Carcinoma

por Gross-Goupil, Marine, François, Louis, Quivy, Amandine, Ravaud, Alain
Publicado 2013

Adaptation of multidisciplinary meeting decisions in a medical oncology department during the COVID epidemic in a less affected region of France: a prospective analysis from Bordea...

por Heraudet, Luc, Domblides, Charlotte, Daste, Amaury, Gross-Goupil, Marine, Ravaud, Alain
Publicado 2020

Metastatic non-muscle invasive bladder cancer with meningeal carcinomatosis: case report of an unexpected response

por Teyssonneau, Diego, Daste, Amaury, Dousset, Vincent, Hoepffner, Jean-Luc, Ravaud, Alain, Gross-Goupil, Marine
Publicado 2017

An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives

por Iaxx, Romain, Lefort, Felix, Domblides, Charlotte, Ravaud, Alain, Bernhard, Jean-Christophe, Gross-Goupil, Marine
Publicado 2022

Feasibility of robotic-assisted partial nephrectomy for complete remission of metastatic renal cell carcinoma after long exposure to immune checkpoint inhibitors (UroCCR-106)

por Mebroukine, Samy, Yacoub, Mokrane, Michiels, Clément, Ravaud, Alain, Gross-Goupil, Marine, Bernhard, Jean-Christophe
Publicado 2022

Optimal management of renal cell carcinoma in the elderly: a review

por Quivy, Amandine, Daste, Amaury, Harbaoui, Asma, Duc, Sophie, Bernhard, Jean-Christophe, Gross-Goupil, Marine, Ravaud, Alain
Publicado 2013

Therapeutic Management of Metastatic Clear Cell Renal Cell Carcinoma: A Revolution in Every Decade

por Larroquette, Mathieu, Lefort, Félix, Heraudet, Luc, Bernhard, Jean-Christophe, Ravaud, Alain, Domblides, Charlotte, Gross-Goupil, Marine
Publicado 2022

Management of Immune Checkpoint Inhibitor Toxicities

por Durrechou, Quentin, Domblides, Charlotte, Sionneau, Baptiste, Lefort, Felix, Quivy, Amandine, Ravaud, Alain, Gross-Goupil, Marine, Daste, Amaury
Publicado 2020

Combinations of Anti-Angiogenic Agents and Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Best Option?

por Granet-Vaissiere, Estelle, Lefort, Félix, Domblides, Charlotte, Larroquette, Mathieu, Ravaud, Alain, Bernhard, Jean-Christophe, Gross-Goupil, Marine
Publicado 2023

Renal cell carcinoma lung metastases treated by radiofrequency ablation integrated with systemic treatments: over 10 years of experience

por Gonnet, Alexis, Salabert, Laura, Roubaud, Guilhem, Catena, Vittorio, Brouste, Véronique, Buy, Xavier, Gross Goupil, Marine, Ravaud, Alain, Palussière, Jean
Publicado 2019

First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?

por Vano, Yann-Alexandre, Ladoire, Sylvain, Elaidi, Réza, Dermeche, Slimane, Eymard, Jean-Christophe, Falkowski, Sabrina, Gross-Goupil, Marine, Malouf, Gabriel, Narciso, Bérangère, Sajous, Christophe, Tartas, Sophie, Voog, Eric, Ravaud, Alain
Publicado 2021

Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma

por de Vries-Brilland, Manon, Rioux-Leclercq, Nathalie, Meylan, Maxime, Dauvé, Jonathan, Passot, Christophe, Spirina-Menand, Elena, Flippot, Ronan, Fromont, Gaëlle, Gravis, Gwenaelle, Geoffrois, Lionnel, Chevreau, Christine, Rolland, Fréderic, Blanc, Ellen, Lefort, Félix, Ravaud, Alain, Gross-Goupil, Marine, Escudier, Bernard, Negrier, Sylvie, Albiges, Laurence
Publicado 2023

Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma

por Powles, Thomas, Motzer, Robert J., Escudier, Bernard, Pal, Sumanta, Kollmannsberger, Christian, Pikiel, Joanna, Gurney, Howard, Rha, Sun Young, Park, Se Hoon, Geertsen, Poul F., Gross-Goupil, Marine, Grande, Enrique, Suarez, Cristina, Markby, David W., Arroyo, Alan, Dean, Mark, Choueiri, Toni K., George, Daniel
Publicado 2018

Multicentric phase II trial of TI‐CE high‐dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors

por Chevreau, Christine, Massard, Christophe, Flechon, Aude, Delva, Rémy, Gravis, Gwenaëlle, Lotz, Jean‐Pierre, Bay, Jacques‐Olivier, Gross‐Goupil, Marine, Fizazi, Karim, Mourey, Loïc, Paci, Angelo, Guitton, Jérôme, Thomas, Fabienne, Lelièvre, Bénédicte, Ciccolini, Joseph, Moeung, Sotheara, Gallois, Yohan, Olivier, Pascale, Culine, Stéphane, Filleron, Thomas, Chatelut, Etienne
Publicado 2021

Immune checkpoint inhibitor rechallenge in patients who previously experienced immune-related inflammatory arthritis: a multicentre observational study

por Ladouceur, Alexandra, Barnetche, Thomas, Mouterde, Gael, Tison, Alice, Bitoun, Samuel, Prey, Sorilla, Dutriaux, Caroline, Gerard, Emilie, Pham-Ledard, Anne, Beylot-Barry, Marie, Zysman, Maeva, Veillon, Rémi, Domblides, Charlotte, Daste, Amaury, Gross-Goupil, Marine, Sionneau, Baptiste, Lefort, Felix, Larroquette, Mathieu, Richez, Christophe, Truchetet, Marie-Elise, Schaeverbeke, Thierry, Kostine, Marie
Publicado 2023

Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data

por Thurin, Nicolas H., Bosco-Levy, Pauline, Blin, Patrick, Rouyer, Magali, Jové, Jérémy, Lamarque, Stéphanie, Lignot, Séverine, Lassalle, Régis, Abouelfath, Abdelilah, Bignon, Emmanuelle, Diez, Pauline, Gross-Goupil, Marine, Soulié, Michel, Roumiguié, Mathieu, Le Moulec, Sylvestre, Debouverie, Marc, Brochet, Bruno, Guillemin, Francis, Louapre, Céline, Maillart, Elisabeth, Heinzlef, Olivier, Moore, Nicholas, Droz-Perroteau, Cécile
Publicado 2021

Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma

por Oudard, Stephane, Benhamouda, Nadine, Escudier, Bernard, Ravel, Patrice, Tran, Thi, Levionnois, Emeline, Negrier, Sylvie, Barthelemy, Philippe, Berdah, Jean François, Gross-Goupil, Marine, Sternberg, Cora N., Bono, Petri, Porta, Camillo, Giorgi, Ugo De, Parikh, Omi, Hawkins, Robert, Highley, Martin, Wilke, Jochen, Decker, Thomas, Tanchot, Corinne, Gey, Alain, Terme, Magali, Tartour, Eric
Publicado 2021

REchallenge of NIVOlumab (RENIVO) or Nivolumab-Ipilimumab in Metastatic Renal Cell Carcinoma: An Ambispective Multicenter Study

por Vauchier, Charles, Auclin, Edouard, Barthélémy, Philippe, Carril-Ajuria, Lucia, Ryckewaert, Thomas, Borchiellini, Delphine, Castel-Ajgal, Zahra, Bennamoun, Mostefa, Campedel, Luca, Thiery-Vuillemin, Antoine, Coquan, Elodie, Crouzet, Laurence, Berdah, Jean-François, Chevreau, Christine, Ratta, Raffaele, Fléchon, Aude, Lefort, Felix, Albiges, Laurence, Gross-Goupil, Marine, Vano, Yann-Alexandre, Thibault, Constance, Oudard, Stéphane
Publicado 2022